McDonnell Boehnen Hulbert & Berghoff LLP partner Dr. Kevin E. Noonan is quoted in a January 13, 2015 edition of The Wall Street Journal Pharmalot Blog in an article entitled, “Pfizer Warns UK Docs About Patent Infringement Over a Generic Lyrica.” In an unusual move, Pfizer has written to physician groups in the U.K. to warn that prescribing generic versions of its Lyrica medicine – specifically, for treating pain – would violate its patent. But the missive has concerned the largest group of U.K. doctors, underscoring the tension that drug makers sometimes encounter when efforts to enforce patent rights bumps up against patient access. View the article